Chief, Division of Infectious Diseases Roger Williams Medical Center
Infectious Disease
Dr. Gail Skowron, MD
|
|
Give Review
Gail Skowron works in the field of Infectious Disease. She studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care She received awards:"Hope is a Vaccine Award", "Business Women Award", "15th Annual AIDS Seder of Hope Local Hero" and "Top Docs in Rhode Island". Gail Skowron is a published doctor and has 41 publications published. The lastest was: 'Lack of pharmacokinetic interaction between nelfinavir and nevirapine.' She is registered with Medicare and accepts Medicare payments.
Publications
- A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cells.
- Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells.
- Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes.
- Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy.
- The use of protease inhibitors. A sampling of opinions. Interview by Deborah J Cotton.
- dNN study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions.
- A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. Amer...
- The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized ...
- Lack of pharmacokinetic interaction between nelfinavir and nevirapine.
- A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus.
- gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.
- Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole.
- ddC (zalcitabine).
- 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.
- HIV clinical trials in Rhode Island.
- Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
- Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. AIDS Clinical Trial Research...
- A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.
- HIV-1 env-specific cellular cytotoxicity in HIV-1-seropositive mothers and their infants.
- Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
- Toxoplasma peritonitis in a patient with acquired immunodeficiency syndrome.
- Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
- Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired...
- Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-r...
- Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
- Causes of death in persons with human immunodeficiency virus infection.
- Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.
- Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.
- Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
- Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
- Persistent and relapsing babesiosis in immunocompromised patients.
- Truvada intolerance.
- Influenza A H5N1 hemagglutinin cleavable signal sequence substitutions.
- HIV-1 GP120 V3 conformational and informational entropies.
- The HF-SCF energy of HIV-1 MNgp120 V3 hairpin loop conformers.
- Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults.
- Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in ...
- Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.
- Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
- Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.
Schools
Columbia University College Of Physicians and Surgeons
St LukeS Hospital
Stanford University Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Hope is a Vaccine Award
- Business Women Award
- 15th Annual AIDS Seder of Hope Local Hero
- Top Docs in Rhode Island
Education
-
Stanford University -
St Luke's-Roosevelt Hospital Center -
Columbia University College of Physicians & Surgeons
Drug Facts
| NPI NUMBER | 1619934254 | |
| NPPES Provider LastName | SKOWRON | |
| NPPES Provider FirstName | GAIL | |
| NPPES Provider ZIPCode | 029084325 | |
| NPPES Provider State | RI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1230.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619934254 |
| Last Name Of The Provider | SKOWRON |
| First Name Of The Provider | GAIL |
| View All |
Similar Doctors
|
|
Dr. Rami A. Kantor, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bettina M. Knoll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francine Touzard Romo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lalitha Koduri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle A. Lally, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John R. Lonks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charlene Flash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antone A. Medeiros, MD
This Doctor is OpenDoctor Recommended.
|